Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease

American Journal of Pediatric Hematology/Oncology

Volumn 19, Issue 4, 1997, Pages 313-318

  De Montalembert, M ^a   Belloy, M ^b   Bernaudin, F ^c   Gouraud, F ^d   Capdeville, R ^e   Mardini, R ^e   Philippe, N ^e   Jais, J P ^a   Bardakdjian, J ^c   Ducrocq, R ^b   Maier Redelsperger, M ^f   Elion, J ^b   Labie, D ^g   Girot, R ^f  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d ARMAND TROUSSEAU HOSPITAL   (France)

^e HÔPITAL DEBROUSSE   (France)

^f HÔPITAL TENON   (France)

^g Université Paris Descartes   (France)

Author keywords

Children; Fetal hemoglobin; Growth; Hydroxyurea; Painful crisis; Sickle cell disease

Indexed keywords

HEMOGLOBIN F; HYDROXYUREA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FETAL HEMOGLOBIN; FOLLOW-UP STUDIES; GROWTH; HAIR; HEMOGLOBINS; HUMANS; HYDROXYUREA; HYPERPIGMENTATION; KIDNEY DISEASES; LIVER DISEASES; MALE; NAIL DISEASES; PUBERTY;

EID: 0030696806     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199707000-00009     Document Type: Article

References (18)

1. Charache S, Terrin ML, Moore RD, et al. Effect of Hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995; 332: 1317-22.
2. Ferster A, Vermylen C, Cornu G, et al. Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood 1996; 88: 1960-4.
3. Rodgers GP, Dover GJ, Noguchi CT, et al. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Med 1990; 322: 1037-45.
4. SAS Institute Inc., SAS Technical Report P-229, SAS/STAT Software: Changes and Enhancements, Release 6.07, Cary, NC: SAS Institute Inc.; 1992: 620.
5. Vermylen C, Cornu G, Philippe M, et al. Bone marrow transplantation in sickle cell anemia. Arch Dis Child 1991; 66: 1195-8.
6. Walters MC, Patience M, Leisenring W, et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996; 335: 369-76.
7. Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood 1993; 81: 1109-23.
8. Schubert TT. Hepatobiliary system in sickle cell disease. Gastroenterology 1986; 90: 2013-21.
9. Sharon R, Tatarsky I, Ben-Arieh Y. Treatment of polycythemia vera with hydroxyurea. Cancer 1986; 57: 718-20.
10. Scott JP, Hillery CA, Brown ER, et al. Hydroxyurea therapy in children severely affected with sickle cell disease. J Pediatr 1996; 128: 820-8.
11. Fruchtman SM, Kaplan ME, Peterson P, et al. Acute leukemia, hydroxyurea and polycythemia vera: an analysis of risk from the Polycythemia Vera Study Group. Blood 1994; 84 (Suppl 1): 518a.
12. Triadou P, Maier-Redelsperger M, Krishnamoorty R, et al. Fetal haemoglobin variations following hydroxyurea treatment in patients with cyanotic congenital heart disease. Nouv Rev Fr Hematol 1994; 36: 367-72.
13. Rees DC, Thein SW, Dover GJ, et al. Profound increases in fetal hemoglobin during hydroxyurea and butyrate therapy are not associated with reversion to fetal erythropoiesis. Blood 1996; 88 (Suppl 1): 311a.
14. Ho PTC, Murgo AJ. Hydroxyurea and sickle cell crisis. N Engl J Med 1995; 333: 1008.
15. Silver RT. Hydroxyurea and sickle cell crisis. N Engl J Med 1995; 333: 1008-9.
16. Charache S, Dover GJ, Moore RD, et al. Hydroxyurea and sickle cell crisis. Reply. N Engl J Med 1995; 333: 1009.
17. Rodgers GP, Dover GJ, Uyesaka N, et al. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. N Engl J Med 1993; 328: 73-80.
18. Nagel RL, Vichinsky E, Shah M, et al. F reticulocytes response in sickle cell anemia treated with recombinant human erythropoietin: a double blind study. Blood 1993; 81: 9-14.